For investors considering whether to buy, hold or sell the stock, the question now is whether this price run will... Arix Bioscience plc is a United Kingdom-based healthcare and life science company. The difference between the bid and offer prices expressed as a percentage.

Hasn't really shifted the share price, I assume due to Woodford overhang worries, but confirms that currently on offer at a 25% discount to nav. Here’s How To Combat It, According To 10 Experts, Disney Lays Off 28,000 Workers as the Pandemic’s Economic Toll Continues, Boeing set to shift all 787 Dreamliner production to South Carolina, Live blog and video: Trump, Biden face off in first presidential debate, Arix Bioscience plc: Arix to Present at the Proactive One2One Biotech Forum, Arix to Participate in Fireside Chat at the Jefferies Virtual Healthcare Conference, Amplyx Pharmaceuticals Adds Pfizer and Adage to Series C Financing, Bringing Total to over 90 Million, Arix Bioscience plc: Investment Team Changes - Jonathan Tobin, PhD, promoted to Managing Director, Arix Bioscience plc : Imara Files for Proposed Initial Public Offering in the United States, Arix Co-founds Quench Bio With Series A Financing, Quench Bio Closes $50M Series A Financing to Advance First-in-Class Medicines Targeting Gasdermin to Treat Severe Inflammatory Diseases, United States : Pharmaxis Appoints Edward Rayner to Board of Directors. Historical and current end-of-day data provided by FACTSET. * Harpoon completed a successful IPO on Nasdaq, raising $81m; Arix invested

The price at which you can buy a share or investment. Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks, 20 Berkeley Square, LONDON, W1J 6EQ, United Kingdom, Charlotte Parry (Head of Investor Relations), Arix Bioscience PLC Arix Bioscience PLC: Autolus presents additional AUTO3 data in DLBCL, Arix Bioscience PLC Arix Bioscience PLC: Interim Results for the Six Months Ended 30 June 2020, Arix Bioscience plc: LogicBio announces IND clearance for LB-001, Arix Bioscience Plc - Second Price Monitoring Extn. Also even after post y/e fundings, by my calcs there is still well over £70m of cash on the balance sheet. However, I don't expect this to follow through into the Arix share price. So in general terms, the higher the PE, the more expensive the stock is.